Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Miguel Pardos
CEO | Chief Executive Officer | - | 01/06/22 |
Santiago Calavia
PRN | Corporate Officer/Principal | - | - |
Julie Moreau
PRN | Corporate Officer/Principal | - | - |
Kamal Abbasi
PRN | Corporate Officer/Principal | - | - |
Jayne Burrell
LAW | General Counsel | 50 | 02/01/15 |
Nairn McMaster
PRN | Corporate Officer/Principal | - | 01/07/11 |
Emilie Croissant
SAM | Sales & Marketing | - | - |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Cheng Wei Liu
CHM | Chairman | 50 | - |
Miguel Pardos
CEO | Chief Executive Officer | - | 01/06/22 |
Gen Li
BRD | Director/Board Member | - | 27/04/23 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 580 157 084 | 315 849 061 ( 54,44 %) | 0 | 54,44 % |
Información de la empresa
Sinclair Pharma Ltd.
Whitfield Court 30-32 Whitfield Street
W1T 2RQ, London
+44 20 7467 6920
http://www.sinclairpharma.com![Dirección Sinclair Pharma PLC](https://cdn.zonebourse.com/static/address/4004466.png)
Sector
Varia. 1 de ene. | Capi. | |
---|---|---|
+24,53 % | 45,07 mil M | |
+30,99 % | 23,39 mil M | |
+24,13 % | 16,08 mil M | |
+21,15 % | 14,6 mil M | |
+68,67 % | 14,01 mil M | |
-0,05 % | 6787,61 M | |
-13,29 % | 6375,89 M | |
-8,87 % | 5725,52 M | |
+13,53 % | 5639,82 M |